Effects of doxycycline (Dox) on tumor growth, metastasis, and leukocyteinfiltration. (PPTX 2548Â kb
Figure S7. C/EBP-β LIP levels in TetON MDA-MB-231 cells, treated with chloroquine, bortezomib and do...
Graphs present the IC50 with the 95% confidence intervals for the seven tested cell lines obtained f...
The graphs show the proliferation rate (BrdU; in % of control cells) for the seven different breast ...
Figure S3. Representative dose response and time course analysis of doxycycline induction of CPT1A e...
GTCpFE inhibits cytokine-induced NFκB target gene expression in breast cancer cells. MCF-7 cells wer...
Figure S2. Wound healing assays of NC-sh MDA-MB-231 and NC-sh 4 T1 cells upon DGLA treatment vs. con...
Figure S1. CXCL17 did not affect the cell proliferation and migration of breast cancer. The effect o...
FC-IBC02 cell proliferation assays: estimated time trends in response to different CEP-37440 concent...
Figure S2. Chloroquine and bortezomib inhibition of lysosome and proteasome activity. (DOCX 1074âk...
Figure S4. Effect of chloroquine, bortezomib, sodium nitroprusside and carboxy-PTIO on C/EBP-β LIP/C...
Spreadsheet of analyte concentrations and metabolite/parent ratios for tamoxifen and its metabolites...
SUM190 cell proliferation assays: estimated time trends in response to CEP-37440 concentration in th...
Figure S1. LECs increase VEGFR3-dependent invasion of human breast cancer cells after treatment with...
Expression of different markers in various breast cancer cell lines. Western blot showing different ...
Table S1. Sequences of the primers used to detect gene expression by qRT-PCR. Table S2. Characteriza...
Figure S7. C/EBP-β LIP levels in TetON MDA-MB-231 cells, treated with chloroquine, bortezomib and do...
Graphs present the IC50 with the 95% confidence intervals for the seven tested cell lines obtained f...
The graphs show the proliferation rate (BrdU; in % of control cells) for the seven different breast ...
Figure S3. Representative dose response and time course analysis of doxycycline induction of CPT1A e...
GTCpFE inhibits cytokine-induced NFκB target gene expression in breast cancer cells. MCF-7 cells wer...
Figure S2. Wound healing assays of NC-sh MDA-MB-231 and NC-sh 4 T1 cells upon DGLA treatment vs. con...
Figure S1. CXCL17 did not affect the cell proliferation and migration of breast cancer. The effect o...
FC-IBC02 cell proliferation assays: estimated time trends in response to different CEP-37440 concent...
Figure S2. Chloroquine and bortezomib inhibition of lysosome and proteasome activity. (DOCX 1074âk...
Figure S4. Effect of chloroquine, bortezomib, sodium nitroprusside and carboxy-PTIO on C/EBP-β LIP/C...
Spreadsheet of analyte concentrations and metabolite/parent ratios for tamoxifen and its metabolites...
SUM190 cell proliferation assays: estimated time trends in response to CEP-37440 concentration in th...
Figure S1. LECs increase VEGFR3-dependent invasion of human breast cancer cells after treatment with...
Expression of different markers in various breast cancer cell lines. Western blot showing different ...
Table S1. Sequences of the primers used to detect gene expression by qRT-PCR. Table S2. Characteriza...
Figure S7. C/EBP-β LIP levels in TetON MDA-MB-231 cells, treated with chloroquine, bortezomib and do...
Graphs present the IC50 with the 95% confidence intervals for the seven tested cell lines obtained f...
The graphs show the proliferation rate (BrdU; in % of control cells) for the seven different breast ...
DOI
Add to ORKG